Option Care Health (NASDAQ:OPCH) Sets New 52-Week Low – What’s Next?

Option Care Health, Inc. (NASDAQ:OPCH) shares reached a new 52-week low during trading on Wednesday . The company traded as low as $22.20 and last traded at $22.28, with a volume of 747109 shares changing hands. The stock had previously closed at $22.85.

Analysts Set New Price Targets

Several equities analysts recently commented on the company. Barrington Research reduced their target price on Option Care Health from $40.00 to $32.00 and set an “outperform” rating for the company in a research report on Thursday, October 31st. Jefferies Financial Group lowered Option Care Health from a “buy” rating to a “hold” rating and cut their price objective for the stock from $38.00 to $26.00 in a report on Thursday, October 31st. Bank of America downgraded shares of Option Care Health from a “buy” rating to a “neutral” rating and lowered their target price for the company from $43.00 to $29.00 in a research note on Wednesday, October 30th. The Goldman Sachs Group lowered shares of Option Care Health from a “buy” rating to a “neutral” rating and decreased their price target for the stock from $38.00 to $27.00 in a report on Monday, November 4th. Finally, JMP Securities upped their target price on shares of Option Care Health from $36.00 to $37.00 and gave the stock a “market outperform” rating in a research report on Monday, September 30th. Three investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $30.83.

Option Care Health Trading Up 0.0 %

The stock’s fifty day simple moving average is $28.82 and its two-hundred day simple moving average is $29.44. The firm has a market cap of $3.78 billion, a PE ratio of 18.65, a PEG ratio of 2.30 and a beta of 1.32. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77.

Insiders Place Their Bets

In other news, Director Harry M. Jansen Kraemer, Jr. bought 43,000 shares of the company’s stock in a transaction that occurred on Friday, November 8th. The stock was bought at an average price of $22.54 per share, with a total value of $969,220.00. Following the acquisition, the director now owns 326,334 shares of the company’s stock, valued at approximately $7,355,568.36. This represents a 15.18 % increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Elizabeth Quadros Betten sold 47,531 shares of the business’s stock in a transaction dated Wednesday, August 21st. The shares were sold at an average price of $31.09, for a total value of $1,477,738.79. Following the completion of the transaction, the director now owns 21,339 shares in the company, valued at $663,429.51. The trade was a 69.02 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.64% of the stock is owned by insiders.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently modified their holdings of the company. UMB Bank n.a. increased its holdings in shares of Option Care Health by 937.5% in the 3rd quarter. UMB Bank n.a. now owns 830 shares of the company’s stock worth $26,000 after buying an additional 750 shares during the last quarter. GAMMA Investing LLC increased its stake in Option Care Health by 110.6% during the third quarter. GAMMA Investing LLC now owns 897 shares of the company’s stock worth $28,000 after acquiring an additional 471 shares during the last quarter. Whittier Trust Co. of Nevada Inc. raised its position in Option Care Health by 3,362.8% during the third quarter. Whittier Trust Co. of Nevada Inc. now owns 1,489 shares of the company’s stock valued at $47,000 after purchasing an additional 1,446 shares during the period. Blue Trust Inc. lifted its stake in shares of Option Care Health by 14.8% in the 2nd quarter. Blue Trust Inc. now owns 2,931 shares of the company’s stock valued at $81,000 after purchasing an additional 377 shares during the last quarter. Finally, SageView Advisory Group LLC purchased a new position in shares of Option Care Health in the 1st quarter worth approximately $85,000. 98.05% of the stock is currently owned by institutional investors.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.